AU7173698A - Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls - Google Patents
Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce llsInfo
- Publication number
- AU7173698A AU7173698A AU71736/98A AU7173698A AU7173698A AU 7173698 A AU7173698 A AU 7173698A AU 71736/98 A AU71736/98 A AU 71736/98A AU 7173698 A AU7173698 A AU 7173698A AU 7173698 A AU7173698 A AU 7173698A
- Authority
- AU
- Australia
- Prior art keywords
- lls
- lipophilic
- nucleic acids
- specific delivery
- lytic peptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4529597P | 1997-05-02 | 1997-05-02 | |
| US60045295 | 1997-05-02 | ||
| PCT/US1998/008849 WO1998050078A1 (en) | 1997-05-02 | 1998-04-30 | Lipophilic and/or lytic peptides for specific delivery of nucleic acids to cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7173698A true AU7173698A (en) | 1998-11-27 |
Family
ID=21937081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU71736/98A Abandoned AU7173698A (en) | 1997-05-02 | 1998-04-30 | Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7173698A (en) |
| WO (1) | WO1998050078A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1052288A1 (en) * | 1999-05-10 | 2000-11-15 | Transgene S.A. | Complex for transferring an anionic substance of interest into a cell |
| EP1052287A3 (en) * | 1999-05-10 | 2003-07-09 | Transgene S.A. | Complex for transferring an anionic substance of interest into a cell |
| EP1170373A1 (en) * | 2000-07-03 | 2002-01-09 | Retina France | Peptide-mediated ocular cell transfection |
| US7446099B2 (en) | 2004-02-27 | 2008-11-04 | Nitto Denko Corporation | Compositions and methods for biodegradable polymer-peptide mediated transfection |
| FR2966827B1 (en) * | 2010-10-27 | 2014-08-22 | Kimonella Ventures Ltd | PEPTIDE COMPOUND USEFUL FOR INHIBITING AMYLOID PLATE FORMATION |
| CA2831392C (en) | 2011-03-28 | 2020-04-28 | Massachusetts Institute Of Technology | Conjugated lipomers and uses thereof |
| KR102451116B1 (en) * | 2011-10-27 | 2022-10-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | Amino acid derivatives functionalized on the n-terminal capable of forming drug incapsulating microspheres |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11506722A (en) * | 1995-06-07 | 1999-06-15 | ベイラー・カレッジ・オブ・メディスン | Nucleic acid carriers for delivering nucleic acids to cells |
| US6344436B1 (en) * | 1996-01-08 | 2002-02-05 | Baylor College Of Medicine | Lipophilic peptides for macromolecule delivery |
| EP0784984B1 (en) * | 1996-01-17 | 2003-07-02 | F. Hoffmann-La Roche Ag | Transfection competent molecules |
| US5948681A (en) * | 1996-08-14 | 1999-09-07 | Children's Hospital Of Philadelphia | Non-viral vehicles for use in gene transfer |
-
1998
- 1998-04-30 AU AU71736/98A patent/AU7173698A/en not_active Abandoned
- 1998-04-30 WO PCT/US1998/008849 patent/WO1998050078A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998050078A1 (en) | 1998-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL336889A1 (en) | Preparations of activated protein c | |
| EP0948513A4 (en) | Delivery construct for antisense nucleic acids and methods of use | |
| HUP0003761A3 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| IL116458A0 (en) | Aerosol formulations of peptides and proteins | |
| HUP9801207A3 (en) | Therapeutic compositions for transfecting nucleic acids and use thereof | |
| AU4231897A (en) | Compositions and methods for delivery of nucleic acids to hepatocytes | |
| HUP0001272A3 (en) | Direct expression of peptides into culture media | |
| HU9502702D0 (en) | Dna constructs that contain influenza-virus genes and pharmaceutical preparations containing them | |
| AU8264898A (en) | Human jagged polypeptide, encoding nucleic acids and methods of use | |
| AUPN741696A0 (en) | Delivery of nucleic acids ii | |
| AU1222901A (en) | Polypeptides having phospholipase b activity and nucleic acids encoding same | |
| AU4960797A (en) | Use of nucleic acids bound to carrier macromolecules | |
| EP1007706A4 (en) | Rna binding protein and binding site useful for expression of recombinant molecules | |
| AU2773695A (en) | Compositions for and methods of enhancing delivery of nucleic acids to cells | |
| PL337942A1 (en) | Isolated genes of dendricall cell membranic proteins | |
| IL113484A0 (en) | Viral proteins pharmaceutical compositions containing them their preparation and use | |
| AU7758598A (en) | Stable pharmaceutical administration forms of peptides, proteins and nucleic acids | |
| AU1870597A (en) | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof | |
| AU7173698A (en) | Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls | |
| AU7378196A (en) | Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof | |
| NO991839D0 (en) | Methods and Preparations for Delivery and Expression of Interferon <alfa> Nucleic Acids | |
| IL123849A0 (en) | Pharmaceutical composition useful for nucleic acid transfection and use thereof | |
| AU5602100A (en) | Recombinant prion-like genes and proteins and materials and methods comprising same | |
| GB9515356D0 (en) | Improvements in or relating to delivery of nucleic acid | |
| AU4904097A (en) | Gene delivery and expression in areas inaccessible to direct protein delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |